Skip to content

Mohammad Khan

NPI 1306008917ActiveIndividual· Internal Medicine, Infectious Disease· Greenville, SC

Internal Medicine, Infectious Disease in Greenville, South Carolina, licensed in SC, with an NPI issued in June 2008. Part D covered 23 prescriptions written in 2024, 87% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. reported $19.60 in payments in 2025, mostly food and beverage.

Overview

NPI1306008917
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJun 26, 2008
Last updated in NPPESJun 26, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Infectious Disease Primary207RI0200X16684SC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)23 · 53 30-day fills
Total drug cost$671.96
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$19.60 · 1 payment from 1 company
  • 2024$293.90 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Boehringer Ingelheim Pharmaceuticals, Inc.$19.601

What the 2025 payments were for

  • Food and Beverage$19.60 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Infectious Disease providers in Greenville

All Internal Medicine, Infectious Disease providers in South Carolina →